Back to User profile » Dr Ruben Mesa
Papers published by Dr Ruben Mesa:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
Singer JW, Al-Fayoumi S, Ma H, Komrokji RS, Mesa R, Verstovsek S
Journal of Experimental Pharmacology 2016, 8:11-19
Published Date: 16 August 2016
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of pomalidomide and its potential in the treatment of myelofibrosis
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/1xEV8_xPTlk/1.jpg)
Gowin KL, Mesa RA
Therapeutics and Clinical Risk Management 2015, 11:549-556
Published Date: 2 April 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes
Verstovsek S, Gotlib J, Gupta V, Atallah E, Mascarenhas J, Quintas-Cardama A, Sun W, Sarlis NJ, Sandor V, Levy RS, Kantarjian HM, Mesa RA
OncoTargets and Therapy 2014, 7:13-21
Published Date: 17 December 2013
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Ruxolitinib as an emerging treatment in myelofibrosis
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/vPI5I9tVkZU/1.jpg)
Emanuel RM, Geyer HL, Mesa RA
Blood and Lymphatic Cancer: Targets and Therapy 2013, 3:11-18
Published Date: 9 March 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Recent developments in myelofibrosis
Tibes R, Bogenberger JM, Mesa RA
Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:125-136
Published Date: 2 July 2012